Diagnostic Tools for Alzheimer’s Disease: A Narrative Review Based on Our Own Research Experience
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Alzheimer’s disease (AD), one of the most representative neurodegenerative diseases, has diverse neurobiological and pathophysiological mechanisms. Treatment strategies targeting a single mechanism have repeated faced failures because the mechanism of neuronal cell death is very complex that is not fully understood yet. Since complex mechanisms exist to explain AD, a variety of diagnostic biomarkers for diagnosing AD are required. Moreover, standardized evaluations for comprehensive diagnosis using neuropsychological, imaging, and laboratory tools are needed. In this review, we summarize the latest clinical, neuropsychological, imaging, and laboratory evaluations to diagnose patients with AD based on our own experience in conducting a prospective study.
Abstract
Alzheimer’s disease (AD), one of the most representative neurodegenerative diseases, has diverse neurobiological and pathophysiological mechanisms. Treatment strategies targeting a single mechanism have repeated faced failures because the mechanism of neuronal cell death is very complex that is not fully understood yet. Since complex mechanisms exist to explain AD, a variety of diagnostic biomarkers for diagnosing AD are required. Moreover, standardized evaluations for comprehensive diagnosis using neuropsychological, imaging, and laboratory tools are needed. In this review, we summarize the latest clinical, neuropsychological, imaging, and laboratory evaluations to diagnose patients with AD based on our own experience in conducting a prospective study.
참고문헌 (21)
- 김승현, "A Therapeutic Strategy for Alzheimer's Disease Focused on Immune-inflammatory Modulation", Dementia and Neurocognitive Disorders(대한치매학회지), 18(2), pp.33~46 (2019), 대한치매학회[DOI]
- Jack CR Jr, "NIA-AA research framework : toward a biological definition of Alzheimer’s disease", Alzheimers Dement, 14, pp.535~562 (2018)
- Dubois B, "Clinical diagnosis of Alzheimer’s disease : recommendations of the International Working Group", Lancet Neurol, 20, pp.484~496 (2021)
- 장승민, "Constructing a Composite Score for the Seoul Neuropsychological Screening Battery-Core", Dementia and Neurocognitive Disorders(대한치매학회지), 14(4), pp.137~142 (2015), 대한치매학회[DOI]
- Pasquier F, "Inter-and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts", Eur Neurol, 36, pp.268~272 (1996)
- Scheltens P, "Atrophy of medial temporal lobes on MRI in"probable"Alzheimer’s disease and normal ageing : diagnostic value and neuropsychological correlates", J Neurol Neurosurg Psychiatry, 55, pp.967~972 (1992)
- Enkirch SJ, "The ERICA score : an MR imaging-based visual scoring system for the assessment of entorhinal cortex atrophy in Alzheimer disease", Radiology, 288, pp.226~333 (2018)
- Wattjes MP, "Diagnostic imaging of patients in a memory clinic : comparison of MR imaging and 64-detector row CT", Radiology, 253, pp.174~183 (2009)
- Cavallin L, "Overtime reliability of medial temporal lobe atrophy rating in a clinical setting", Acta Radiol, 53, pp.318~323 (2012)
- Claus JJ, "Practical use of visual medial temporal lobe atrophy cut-off scores in Alzheimer’s disease : validation in a large memory clinic population", Eur Radiol, 27, pp.3147~3155 (2017)
- 문원진, "알츠하이머 치매와 미세뇌혈관병리: 혈액뇌장벽 투과도 영상", 대한영상의학회지, 81(3), pp.488~500 (2020), 대한영상의학회[DOI]
- 박미나, "Structural MR Imaging in the Diagnosis of Alzheimer’s Disease and Other Neurodegenerative Dementia: Current Imaging Approach and Future Perspectives", Korean Journal of Radiology, 17(6), pp.827~845 (2016), 대한영상의학회[DOI]
- Fazekas F, "MR signal abnormalities at 1. 5 T in Alzheimer’s dementia and normal aging", AJR Am J Roentgenol, 149, pp.351~356 (1987)
- Moon Y, "Regional atrophy of the insular cortex is associated with neuropsychiatric symptoms in Alzheimer’s disease patients", Eur Neurol, 71, pp.223~229 (2014)
- Thrippleton MJ, "Quantifying blood-brain barrier leakage in small vessel disease : review and consensus recommendations", Alzheimers Dement, 15, pp.840~858 (2019)
- Lee Ji Young, "뇌 자기공명영상 뇌용적 분석 소프트웨어의 임상적 적용에 대한 전문가 의견과 권고안", 대한영상의학회지, 82(5), pp.1124~1139 (2021), 대한영상의학회[DOI]
- So Yeong Jeong, "퇴행성 뇌질환에서 뇌 자기공명영상 기반 인공지능 소프트웨어 활용의 현재", 대한영상의학회지, 83(3), pp.473~485 (2022), 대한영상의학회
- Moon Y, "A Guide for Researchers in Precision Medicine Based on Immune Modulation in Alzheimer’s Disease" (2023), Median Book
- Farber SA, "Regulated secretion of beta-amyloid precursor protein in rat brain", J Neurosci, 15, pp.7442~7451 (1995)
- Rosen RF, "SDS-PAGE", immunoblot detection of Aβ multimers in human cortical tissue homogenates using antigen-epitope retrieval, 2010, 1916~
- Milà-Alomà M, "Latest advances in cerebrospinal fluid and blood biomarkers of Alzheimer’s disease", Ther Adv Neurol Disorder, 12 (2019)